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Purpose: This study was undertaken to determine the mortality and morbidity rates 
associated with abdominal aortic aneurysm (AAA) repair in octogenarians and to identify 
factors that may influence survival in this age group. 
Methods: One hundred fourteen patients (mean age 83 years) were admitted consecutively 
with 106 infrarenal and eight juxtarenal AAAs from 1984 through 1993. Ninety-four 
AAAs were asymptomatic, whereas 20 patients with symptoms had 11 intact and nine 
ruptured AAAs. The mean AAA diameter was 6.7 cm. Repair consisted of aortic 
bifurcation grafts in 77 patients (67%), tube grafts in 35 (31%), and extraanatomic 
procedures in2 (2%). A total of 29 patients (25%) had undergone previous coronary artery 
bypass (24 patients) or transluminal coronary angioplasty (five patients) either incidentally 
or as a preliminary procedure before resection of their AAAs. 
Results: The 30-day mortality rate for the entire series was 14%, but it declined from 23% 
(11/48) during the first 5 years to 8% (5/66) during the second 5years of the study period 
(p = 0.028). Fatal complications occurred in nine (9.6%) of the 94 patients with 
asymptomatic AAAs and in seven (35%) of the 20 patients who had symptomatic AAAs 
(p = 0.008). Considering only patients with asymptomatic AAAs, the early mortality rate 
in the second 5years (4%) improved signifieandy (p = 0.038) in comparison to that (17%) 
for the first 5 years of the study period. 
The cumulative 5-year survival rate of 48% for 97 available operative survivors was not 
quite so good as that (59%) for the normal male population of the United States at the 
age of 80 years (p < 0.0001). Nevertheless, the 5-year survival rate was 80% for 27 
operative survivors who received previous myocardial revascularization compared with 
38% for 70 others who did not (to = 0.0077). Multiple Cox-regression a alysis identified 
the perioperative homologous blood requirement (p = 0.03) and a history of previous 
myocardial revascularization (p = 0.03) as significant independent factors influencing late 
survival. 
Conclusions: Repair of AAAs in properly selected octogenarians is safe and durable. When 
otherwise indicated, it should not be withheld on the basis of advanced age alone. Prior 
treatment of severe coronary artery disease is associated with enhanced late survival, but 
patient selection probably is an important consideration i this respect. 0 VAsc SUKG 
1995;21:830-8.) 
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A number of factors probably have contributed to 
a perceived increase in the number of  elderly patients 
who now come under serious consideration for repair 
of abdominal aortic aneurysms (AAAs), such as an 
aging population, greater physician and public 
awareness of  the prevalence of  AAAs, improvements 
in the accuracy of  diagnostic methods, and the safety 
of modern surgical management. Early mortality 
rates after elective, infrarenal AAA repair among 
patients of all ages has steadily declined from almost 
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10% over 20 years agC to as low as 1% to 6% 
according to a few contemporary eports. 2-8 Recent 
unpublished results from our own center confirm 
these trends and are summarized inTable I. The rates 
in Table I are hospital rather than 30-day mortality 
rates. 
For all of these reasons, the indications for graft 
replacement ofAAA generally have been extended to 
include older patients who often have comorbid 
conditions that might be expected to influence their 
operative risk. According to our own departmental 
registry, for example~ octogenarians comprised 66 
(9.1%1 of the 722 panenrs who underwent aortobi- 
iliac or interposition grafts for infrarenal AAAs from 
1989 through i993 (Ur~pub!ished data) Further- 
more, more elderly patients: and patients at high risk 
are likely to require treatment for AAA in the future, 
because current projections indicate that the propor- 
tion of the population of  the United States (U.S.) 
aged 75 years or older Will: double from approxa- 
mately 5% in 1990 to nearly I0% by 2030. 9H The 
consumption of health care resources by the very 
elderly raises legitimate concerns regarding the long- 
term benefits conferred by any major surgical proce- 
dure, and AAA repair is no exception. Consequently, 
this study was undertaken to determine the mortafity 
and morbidity rates associated with AAA resection i  
octogenarians, to document the late survival rate in 
these patients, and to identify clinical factors that may 
influence their ultimate outcome. 
PATIENTS AND METHODS 
We collected retrospectiVe data from the hospital 
records of 1!4 consecutive patients who underwent 
surgical managemen t of  ~ t06 infrarenal and eight 
juxtarenal ~ at the age of 80 years or older from 
1984 through i993. Long-term information was 
obtained uring subsequent office visits or by tele- 
phone Contact with the patients, their immediate 
families, or their local physicians. End points were 
defined as death Or follow-up within 6 months of 
study closure~ Follow-up was complete for 112 
patients, but the remaining two patients were con- 
sidered lost at 1 month and at 8 years, respectively. 
The median surveillance period for the entire series 
was 2 years (mean 3 years; range 0 to 9 years). 
The study group consisted of 89 men and 25 
women, with a median age of 83 years (mean 83 
years; range 80 to 94 years) at the time of their 
operations. Seventy-six patients (67%) had clinical 
evidence of coronary artery disease (CAD) defined as 
a convincing history of prior myocardial infarction or 
angina, or either Q-waves or ischemic ST-T wave 
changes on a 12-lead electrocardiogram. Seventy- 
four patients (65%) had hypertension, 8 (7%) had 
diabetes, 15 (13%) had a history of congestive heart 
failure, and 25 (22%) had chronic obstructive pul- 
monary disease. Only 15 patients in this age group 
(13%) still smoked cigarettes. 
Ninety-four AAA (82%) were symptom free, 
whereas 20 patients with symptoms (18%) were 
admitted with 11 intact and nine ruptured AAA. The 
median AAA size was 6.3 cm (mean 6.7 cm; range 
4 to 15 cm) by preoperative noninvasive imaging or 
by direct intraoperative measurement. AAA repair 
was performed with aortic bifurcation grafts in 77 
patients (67%), tube grafts in 35 (31%), and extra- 
anatomic procedures in 2 others (2%). 
A total of 81 patients (71%) were evaluated by 
coronary angiography atsome time before their AAA 
repair. Twenty-nine patients (25 %) underwent either 
coronary artery bypass (24 patients) or transluminal 
coronary angioplasty (5 panents) at a median of 4 
months before operation (mean 36 months; range 10 
days to 18 years). Myocardial revascularization was 
performed within 2 months of AAA repair in only 12 
of these patients, and within 1 year in only five others. 
For the remaining 12 pauents, it was entirely 
incidental. 
Statistical analysis 
Statistical comparisons were made with use of 
Fisher,s exact est (two-tailed) or the chi-square test 
when appropriate. Cumulative survival curves for 
the entire series and for its operative survivors were 
calculated by use of Kaplan-Meier estimates of 
survival distribution. 12 The log-rank test was used 
to test statistical significance (with p < 0.05 con- 
sidered significant) between the Kaplan-Meier es- 
timates of survival distribution for patients who 
underwent previous myocardial revascularization 
and for those who did not. The p Values reported 
refer to differences between Survival distributions. 
Risk factors influencing survival were identified by 
univariate and multivariate analySes for the entire 
series and for operative survivors. Survival analysis 
with multiple Cox-regression models that use a 
backward selection procedure in a statistical analysis 
system (SAS) was used to evaluate the effects of 
individual variables on the patient survival distri- 
bution. 13 
Men outnumbered women by a factor of more 
than 3.5:1 in our study group. Consequently, we 
chose to draw some comparisons to the cumulative 
survival rates for the normal U.S. male population at 
the age of 80 years, which were calculated from U.S. 
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Table I. Hospital mortality rates for aortobiiliac or aortic interposition graft replacement of
infrarenal abdominal aortic aneurysms at the Cleveland Clinic from 1989 through I993 
(unpublished data) 
All ages Age <80 yrs Age >_80 yrs 
Hospital Hospital Hospital 
Patients mortality % Patients mortality % Patients mortality % 
Asymptomatic 626 9 1.4 573 7 1.2 53 2 3.8 
Symptomatic 96 17 18 83 13 16 13 4 31 
Intact 58 7 12 52 5 9.6 6 2 33 
Ruptured 38 10 26 31 8 26 7 2 29 
Total 722 2-6 3.6 65---6 2---0 3.0 6---6 6 9.1 
Table II. Early (30 day) operative mortality data 
Entire series (1984-1993) First 5 years (1984-1988) Second 5years (1989-1993) 
Operative Operative Operative 
No. deaths % No. deaths % No. deaths % p * 
Asymptomatic 94 9 9.6 41 7 17 53 2 3.8 0.038 
Symptomatic 20 7 35 7 4 57 13 3 23 NS 
Intact I 1 4 36 5 3 60 6 1 17 NS 
Ruptured 9 3 33 2 1 50 7 2 29 NS 
Total 11--4 16 14 4--8 1--i 23 6---6 5 7.5 0.028 
NS, Not significant. 
census data 14 by use of the life-table method. For 
these calculations, it was assumed that the Census 
Bureau follow-up was complete and that the annual 
attrition in the patient population at each year of age 
reported in the census data reflected the number of 
deaths during that interval. Although the median age 
of our study group wa s 83 years (mean 83; range 80 
to 94 years), 80 years is the most advanced age for 
which U.S. census data are available to determine a 
5-year survival rate. The 5-year survival rates for the 
study populations used in these comparisons were 
calculated by standard life-table analysis rather than 
by the Kaplan-Meier method. 
RESULTS 
Early mortality 
The 30-day mortality rate was 14% for the entire 
series (Table II), but it declined from 23% (11/48) 
during the first 5 years to 8% (5/66) for the second 
5 years of the study period (p = 0.028). Fatal 
complications occurred in nine (9.6%) of the 94 
patients who had asymptomatic AAAs and in seven 
(35%) of the 20 patients who had preoperative 
symptoms (p = 0.008). Considering the 20 patients 
with symptomatic AAAs the early mortality rate for 
the repair of intact aneurysms, 36% (4/11), was not 
significantly different from that, 33% (3/9), for 
raptured aneurysms. The mortality rates for asymp- 
tomatic AAAs were significantly better than those for 
symptomatic AAA throughout both the first (17% vs 
57%, p = 0.039) and the second (4% vs 23%, 
p = 0.048) 5 years of the series. The early mortality 
rate for patients with asymptomatic AAAs.improved 
significantly during the second 5 years (4% vs 17%, 
p = 0.038), but there were too few patients with 
symptomatic AAAs to reach the same conclusion. 
The early mortality rate for patients with asymp- 
tomatic AAAs who had undergone previous myo- 
cardial revascularization was 4% (1/27), compared 
with 12% (8/67) for those who did not (p = NS). As 
indicated in Table III, the 16 postoperative d aths in 
the entire series were caused by multisystem failure in 
sevcn (44%), by cardiovascular complications (car- 
diac 5; stroke i) in six (37%), by hemorrhage in two 
(13%), and by a ruptured thoracic dissection i  one 
(6%). 
Late survival 
Life-table survival data for all 114 paticnts are 
illustrated in Fig. 1. The cumulative S-year survival 
rate for the complete study group was 41% 
(S.E. = 5.9%). One patient was lost to follow-up on 
the twelfth postoperative day, yielding 97 operative 
survivors available for late consideration (Fig. 1). The 
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Table I I i .  Cause of death for the 
entire series 
Cause of death No. % 
Early 
Multisystem failure 7 44 
Cardiovascular disease 6 37 
Hemorrhage 2 13 
Ruptured thoracic dissection 1 6 
Total 16 100 
Late 
Cancer 12 29 
Cardiovascular disease 7 17 
Neurologic disorders 4 10 
Respiratory failure 4 10 
Gastrointestinal disease 3 7 
Aortoduodenal fistual 1 2 
Undetermined I 1 26 
Total 42 100 
cumulative 5-year survival rate for this cohort was 
48% (S.E. = 6.7%1. The probable causes for a total 
of 42 late deaths are summarized in Table III. 
The overall survival curve for the 29 patients who 
had received previous myocardial revascularizanon 
was superior to that for the 85 patients who had not 
(20 = 0.0038) (Fig. 2, A). The cumulative 5-year 
survival rate was 75% (S.E. = 9.4%) for patients 
who had prior coronary artery bypass or transluminal 
coronary angioplasty, compared with 30% (S.E. - 
6.5%) for all other patients. Within the cohort of 97 
operative survivors, the overall survival curve for the 
27 patients who had undergone myocardial revascu- 
larization also was superior (p - 0.00773 to that for 
the remaining 70 patients who had not (Fig. 2, B). 
Among operanve survivors, the cumulative 5-year 
survival rate for those who underwent previous 
myocardial revascularization was 80% (S .E . -  
9.3%) in comparison to that (37%, S.E. = 7.6%) for 
those who did not. 
The cumulative 5-year survival rate for 97 opera- 
rive survivors (48%) was not quite so good as that 
(59%) for the normal U.S. male population at the age 
of 80 years (p < 0.00011. Nevertheless, the 5-year 
survival rate for 27 operative survivors who received 
previous myocardial revascularization (80%) was 
better (p < 0.0001), and that for 70 others who 
did not (38%) was correspondingly worse (p < 
0.0001 ), than the normal octogenarian survival rate. 
Multivariate analysis 
Risk factors influencing patient survival after suc- 
cessful AAA repair in 97 operative survivors were 
investigated through a Cox-regression model with a 
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Fig. 1. Cumulative survival rate (Kaplan-Meier method) 
for 114 patients in entire series compared with that for 97 
operative survivors. 
backward selection procedure in SAS. la The 10 clini- 
cal features considered in the model were age, sex, 
body surface area, maximum aneurysm diameter, his- 
tory of previous myocardial revascularization, esti- 
mated intraoperative blood loss, preoperative s rum 
creatmine level, preoperative aneurysm symptoms, 
preoperative hematocrit level, and the homologous 
(banked) blood transfusion requirement. The values 
for the continuous variables are summarized inTable 
IV. The noncontinuous variables have been described 
previously in the Patients and Methods ection. This 
model identified the perioperative homologous 
blood transfusion requirement (p = 0.03), andahis- 
tory of previous myocardial revascularization 
(p = 0.03) as the most significant independent fac- 
tors influencing the late survival rate (Table V). Re- 
sidual analyses and log negative log survival function 
plots confirmed that the Cox-regression model fits 
the data. 
When the same 10 variables were investigated 
through alogistic regression analysis with a backward 
selection procedure involving the entire series of 114 
patients, itwas found that the early (30-day) survival 
rate was significantly influenced by symptoms from 
the AAA q0 = 0.01), the preoperative serum creat- 
inine level (p = 0.02) and the perioperative homolo- 
gous blood transfusion requirement (p = 0.0004). 
Considered together, these findings suggest that 
the presence of AAA symptoms and the preoperative 
serum ereatinine level significantly influenced the 
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Table IV. Summary statistics for the continuous clinical variables considered in the 
multivariate analysis 
Variable .Mean Standard eviation n Minimum Maximum 
Age (yr.) 83.2 3 114 80 94 
Aneurysm diameter (cm) 6.7 1.7 112 4 15 
Bank blood requirement (units) 6.2 8.2 113 0 50 
Body surface area (m ~) 1.8 0.18 I l i  1.4 2.2 
Estimated intraoperative blood 2859 1859 110 400 12000 
loss (cc) 
Preoperative hematocrit (%) 37.2 4.8 114 27.7 48 
Preoperative s rum creatinine 1.4 0.5 114 0.7 4.3 
(mg%) 
Preoperative survival interval 31.8 29.6 114 0 108.7 
(too.) 
initial 30-day survival rate but did not influence the 
long-term survival of operative survivors. Con- 
versely, a history of previous myocardial revascular- 
ization did not affect he initial postoperative survival 
rate, but it did favorably influence late survival. A 
high perioperative homologous transfusion require- 
ment had a deleterious effect on both early and late 
survival rates. 
DISCUSSION 
As the population ages, it is realistic to expect that 
more elderly patients will come under consideration 
for AAA repair. During the past 40 years comprising 
the modern era of graft replacement for AAAs, the 
estimated average length of life for the entire U.S. 
population has increased approximately from 68 to 
75 years. 1~ By the year 2030, the proportion of the 
U.S. population older than 75 years is projected to be 
nearly 10%. 9-11 In 1989, the life expectancy for a U.S. 
man attaining the age of 80 was over 7 years, 14 and 
for many these additional yearsare happy and 
productive.ll,ls, 16 
The octogenarians in our series predominantly 
were men with a median age of 83 years. Given the 
large size of the AAAs in our study group (median 
diameter 6.3 cm; mean 6.7 cm) and the several years 
of anticipated risk, the probability of eventual aneu- 
rysm rupture appears to have been substantial. In a 
classic study by Szilagyi et al.,17 the cumulative 5-year 
survival rate for untreated aneurysms larger than 6 cm 
in diameter was only 6.0%. The median survival 
interval for the patients in that report was just 17 
months, and the incidence of fatal aneurysm rupture 
(43%) exceeded the number of deaths caused by 
ischemic heart disease. The subsequent literature 
merely has reconfirmed the importance of AAA size 
as an independent predictor of rupture, 318,19 and 
Cronenwett e  al.z0 have estimated the annual risk for 
rupture to be 6% even for small AAAs (mean 
diameter 3.9 cm). 
The overall 30-day mortality rate for elective 
AAA repair was 9.6% in our series, and it improved 
significantly (from 17% to 4%) during the second 5 
years of our 10-year experience. Others have reported 
similar elective mortality rates ranging from 0% to 
8.6%.6,7,2126 These findings clearly do not imply that 
advanced age is free of liabilities. According to our 
departmental registry (unpublished data), the hospi- 
tal mortality rate for elective surgical treatment in the 
very elderly still is about hree times the comparable 
figure for younger patients (Table I). Nevertheless, 
the early mortality rate for the repair of symptomatic 
AAAs in our octogenarians was 3,6 times the rate for 
symptom-free patients, and it seems unlikely that the 
intrinsic risk of AAA rupture will decline in the 
future. Others have reported nonelective mortality 
rates ranging from 20% to 78% in this age 
group. 6,7,21"26 Therefore, in the absence of end-stage 
vital organ disease, it probably is unreasonable to
withhold AAA repair until symptoms occur in aged 
but otherwise healthy patients, an opinion shared by 
others. 7,8,22-28 
The interpretation f our data related to previous 
intervention for CAD is perhaps the most provoca- 
tive aspect of this report, mad it remains clouded by 
the fact that only small numbers of patients were 
involved, In summary, the early mortality rate for 
patients with AAAs who had undergone previous 
myocardial revascularization was not significantly 
better than the early results for those patients who 
had not. Others have made similar observations, and 
legitimately have argued that careful perioperative 
cardiac management may be as effective as direct 
coronary artery intervention within the limited per- 
spective of early cardiac risk in conjunction with AAA 
resection. 29,3~ It always has been our contention, 
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however, that the major benefit derived from the 
planned surgical treatment of severe associated CAD 
in patients with AAA is its favorable influence on late 
survival.31 Considering either our entire series or only 
its operative survivors, the cumulative late survival 
rate for 29 patients who had undergone either 
previous coronary artery bypass (24 patients) or 
transluminal coronary angioplasty (five patients) was 
superior to that for the majority who had not. The 
importance of this variable was supported by multi- 
variate analysis, yet for several reasons its implications 
are not entirely clear. 
First, coronary artery intervention was performed 
more than a year before AAA repair in 12 of these 29 
patients and therefore does not qualify as being 
planned specifically to enhance its safety. Second, the 
risk of coronary intervention itself in these 12 patients 
may not reflect the expected risk in octogenarians 
because it actually took place at a slightly younger 
age. Finally, despite the fact that onr series of AAA 
repair in octogenarians is reasonably large, the 
effectiveness (or ineffectiveness) of an aggressive 
diagnostic and interventional pproach to incidental 
CAD cannot be established by the results in 12, 29, 
or even 114 patients. Conceding these limitations, we 
believe our data lend themselves to the following, 
cautious interpretations: (1.) Provided their general 
health otherwise is satisfactory, elderly patients with 
a history of successful myocardial revascularization 
are good (not poor) candidates for AAA repair. It 
remains to be seen, however, whether transluminal 
coronary angioplasty will meet the expectations of 
coronary artery bypass in this respect. (2.) The 
elective repair of large AAAs sufficiently enhances 
long-term survival in octogenarians, an observation 
confirmed by others, 24,2t's2 that suspected CAD 
should not be accepted arbitrarily as a surgical 
contraindication without further objective investiga- 
tion by noninvasive myocardial imaging or coronary 
angiography. In our experience, patients found to 
have truly severe (i.e., left main or triple vessel) CAD 
may be amenable to preliminary+ intervention and 
subsequent AAA repair with excellent results. 
In addition to previous myocardial revasculariza- 
tion, multivariate analysis initially identified three 
other variables that appeared to influence survival 
after AAA repair in our entire patient population: the 
presence of symptoms from the aneurysm, the 
homologous blood transfusion requirement, and the 
preoperative serum creatinine level, findings sup- 
ported by others. 4'7'8'22-28'33 For operative survivors, 
the presence of preoperative symptoms and the 
preoperative serum creatinine level no longer re- 
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Fig. 2. A, Cumulative survival (Kaplan-Meier method) 
for all 29 patients who underwent previous coronary artery 
bypass or transluminal coronary angioplasty before AAA 
repair, and for 85 others who did not. Survival distribu- 
tions are significantly different (p = 0.0038, log-ranktest). 
B, Cumulative survival (Kaplan-Meier method) for 27 
operative survivors who underwent previous coronary 
artery bypass or transluminal coronary angioplasty before 
AAA repair, and for 70 operative survivors who did not. 
Survival distributions are significantly different 
(p = 0.0077, log rank test). 
mained as significant factors, suggesting that the 
hazards of urgent operation and renal insufficiency 
were probably confined to the perioperative period 
for our octogenarians. Multivariate analysis con- 
firmed that the homologous blood transfusion re- 
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Table V. Results of Cox-regression a alysis of risk factors associated with late death among 97 
operative survivors 
Variable Parameter estimate Standard error p Value 
Univariate 
Age 0.000888 0.04972 0.9858 
Aneurysm diameter 0.003012 0.10348 0.9768 
Bank blood requirement 0.048923 0.01765 0.0056 
Body surface area - 1.232634 0.95952 0.1989 
Estimated intraoperative blood loss 0.000008 0.00010 0.9359 
Sex 0.004107 0.37560 0.9913 
Preoperative hematocrit - 0.027749 0.03017 0.3577 
Previous myocardial revascularization - 1.090245 0.44235 0.0137 
Preoperative serum creatinine 0.257772 0.41514 0.5346 
Aneurysm symptoms - 0.213881 0.41442 0.6058 
Multivariate 
Bank blood requirement 0.040946 0.01832 0.0255 
Previous myocardial revascularization -0.982876 0.44757 0.0281 
quirement was the only other significant independent 
factor, in addition to a history of previous myocardial 
revascularization, which was determined toinfluence 
the long-term survival of the operative survivors. 
Al~ough the adverse influence of a high transfusion 
requirement on the early postoperative mortality and 
morbidity rates after aortic reconstruction is estab- 
lished, 33,34 the reason for its influence on the long- 
term survival rate for operative survivors is unclear 
and it may be related to other factors that were not 
considered in the regression model. 
We conclude that AAA repair is relatively safe and 
clearly beneficial in elderly patients who are carefully 
selected. When otherwise indicated, it should not be 
withheld on the basis of advanced age alone. For 
operative survivors, late survival is independently and 
favorably influenced by a low perioperative homolo- 
gous transfusion requirement and a history of previ- 
ous myocardial revascularization. The management 
of severe CAD is the factor most under physician 
control in the elective setting, so it deserves particular 
attention. 
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DISCUSSION 
Dr. John D. Corson (Iowa City, Iowa). I agree with 
the authors that aortic aneurysmal disease is now more 
frequently encountered in elderly individuals. Both society 
and the medical profession must adjust o the needs of the 
aging population who provide us with increasingly difficult 
ethical and medical problcms. Often these arc "no-win" 
situations. Inherent in any discussion of surgical intervcn- 
non in elderly patients is a concern of incrcascd morbidity 
and mortality rates, which might negate any benefit of the 
surgical procedure. In this elderly patient population, 
careful balancing of the risks and benefits of an ancurysmal 
procedure is critical. The appropriate treatment of elderly 
patients with aortic aneurysmal disease requires sound 
surgical wisdom and judgment. It is my opinion that a 
vascular surgeon should always bc involved in dccisions 
concerning the appropriate treatment of elderly patients 
with aortic aneurysmal disease, especially in those decisions 
where surgical therapy is deferred. 
The authors have critically reviewed factors that affect 
survival in the octogenarian population undergoing aortic 
aneurysmal replacement. Early survival correlated with the 
patient's symptoms, renal function, and perioperative 
blood transfusion requirements, which would not surprise 
most people. However, late survival correlated with 
perioperative blood transfusion requirements and a history 
of  prior cardiac revascularization. I am at a loss to explain 
the relationship of perioperative blood transfusion require- 
ments to late patient survival and would like Dr. O'Hara to 
expand on this issue further. Interestingly, the history of 
prior cardiac revascularization did not influence early 
survival. The authors point out that this may be due to 
high-quality perioperative invasive monitoring. Of great 
interest are the data concerning cardiac revascularization 
and late survival. The authors report he cause of death in 
42 late survivors and seven are due to cardiovascular causes. 
It is possible that some of the 11 patients in whom the cause 
of death was unknown may have died of heart-related 
causes, which, if true, would further support he author's 
enthusiasm for coronary revascularization, especially if 
these deaths were in the nonrevascularized CAD patient 
group. 
Did the authors use a retroperitoneal approach m any 
of these elderly patients? What preoperative cardiac evalu- 
ation do the authors recommend in the octogenarian 
patient? Did the authors have any deaths in this patient 
population while they were receivmg cardiac services being 
prepared for aortic aneurysm replacement? 
Clearly, patient selection is the key to obtaining ood 
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results in this patient population. Hence, do the authors, 
based on their experience, have any advice about which 
patients we should not be operating on? The geriatric aortic 
aneurysm population is clearly a surgical challenge. The 
surgical results can be very rewarding in the majority of 
well-selected patients. 
Dr. Patrick O'Hara (Cleveland, Ohio). We too were 
puzzled by the influence of the perioperative transfusion 
requirement on late survival and don't have a ready 
explanation for it. We can speculate about the possible 
covariation of  the transfusion requirement and other 
comorbid conditions, but in fact we don't really know why 
it occurred. Its influence may be related to an element in 
our regression model that we did not account for. 
Regarding our current preoperative cardiac evaluation, 
if the octogenarian patient had no preoperative cardiac 
symptoms in the elective situation, we usually obtain some 
form of noninvasive cardiac evaluation, most commonly a
dobutamine stress echo. If the results were positive, then 
we would proceed with coronary angiography and appro- 
priate intervention. On the other hand, if the patient had 
cardiac symptoms, we would proceed with coronary 
angiography initially. 
With regard to deaths during preoperative cardiac 
treatment, it's probable that there were some heart-related 
deaths involved with preoperative myocardial revascnlar- 
ization, but I can't give you a specific number because of the 
design of our study. 
With regard to the retroperitoneal approach question, 
we used the transperitoneal approach more commonly than 
retroperitoneal. However, as time has gone on, we have 
used the retroperitoneal pproach more frequently and 
certainly agree that in some situations itdoes appear to have 
an advantage. We also believe some of the early postoper- 
ative improvement in the last 5 years is related to improved 
anesthesia techniques involving the use of epidural cath- 
eters and better pulmonary management. 
Dr. Walter J. McCarthy (Chicago, I11.). Would you 
comment on the appropriate size for repair of aneurysms in
different age patients? In other words a 7 cm aneurysm in 
an 80-year-old patient seems to be different han a 5 cm 
aneurysm in an 89-year-old patient. 
Dr. O'Hara. The aneurysm size in this group is 
generally larger than that which we use as our usual 
indication to operate. Our threshold is usually 5 cm, and 
the median size was 6.3 (mean 6.7) in this group, so clearly 
our hand was held somewhat in the octogenarian patient. 
As you already pointed out, the larger the aneurysm, the 
lower our threshold is to operate on the patient. 
Dr. William R. Flinn (Baltimore, Md.): Has the man 
lost to follow-up on the twelfth day been found yet? 
Dr. O'Hara. I wish we could have found him because 
it would have made the follow-up more complete. He was 
alive when he was last seen, however. 
Dr. John Blebea (Cincinnati, Ohio). With an aggres- 
sive cardiac evaluation i  these patients, the question is not 
just whether they have had a previous coronary artery 
bypass but actual cardiac function as reflected by left 
ventricular ejection fraction. Could you categorize these 
patients on the basis of measured cardiac function? Are 
these octogenarians in fact patients who have a cardiac 
fimction equivalent to a chronologic 50- or 60-year-old 
patient? 
Dr. Patrick O'Hara. (Cleveland, Ohio). I tried to do 
that but I couldn't get enough consistent data over the span 
of the study span to make sensible conclusions from only 
ventriculography reports. 
Dr. John W. Hallett, Jr. (Rochester, Minn.). In 
looking at your practice, do you know the number of 
octogenarians admitted for surgical consultation but who 
were not offered an operation? 
In your operative group, do you know how long it was 
from the time of AAA diagnosis until a decision was made 
to operate? Perhaps ome of these patients were in their late 
70s when a small AAA was recognized. They may have 
been observed and surprisingly survived to their 80s with 
an enlarging AAA. Do you have time from diagnosis to 
operation and time from coronary revascnlarization u til 
you repair the aneurysms? 
Dr. O'Hara. We do have the figures on the time from 
the coronary artery revascnlarization to aneurysm repair for 
this group, and the interval varied a tremendous amount. 
As I recall, about a third of the myocardial revascularization 
procedures were performed more than a year before AAA 
repair. 
We don't operate on everybody, and there is clearly 
some selection involved. For example I'm reluctant o 
operate on patients who don't have all of their mental 
faculties. They may have Alzheimer's disease, so we 
may not operate on some of those patients if they have 
severe impairment. Pulmonary function is another big 
factor. 
